+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Renal Replacement Therapy Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • July 2024
  • Region: Global
  • The Business Research Company
  • ID: 5986863
The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historic period can be attributed to several factors, including an increased demand for advanced continuous renal replacement therapy (CRRT) devices, a rise in the prevalence and incidence of acute kidney injury (AKI), an increase in the number of medical applications for CRRT, a high prevalence of co-morbidities among patients requiring CRRT, and ongoing research and development efforts in the field.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The forecasted growth can be attributed to several factors, including increasing incidences of chronic kidney diseases, a rising prevalence of diabetes leading to kidney complications, a growing number of intensive care unit (ICU) admissions necessitating renal support, rising investments in healthcare infrastructure to support renal care services, and expanding applications of continuous renal replacement therapy (CRRT) in pediatric care. Major trends expected in the forecast period encompass rapid advancements in CRRT technology, launches of new CRRT technologies, ongoing technological advancements in the field, continuous product innovation, and the introduction of technologically advanced CRRT products catering to diverse patient needs.

The rise in chronic kidney diseases is poised to fuel the growth of the continuous renal replacement therapy market in the coming years. Chronic kidney disease (CKD) is a persistent condition characterized by a gradual decline in kidney function, resulting in the impaired removal of waste products from the bloodstream. Factors contributing to the increasing incidence of chronic kidney diseases include lifestyle shifts, aging demographics, and rising rates of diabetes and hypertension. Continuous renal replacement therapy is employed in managing acute exacerbations or complications of chronic kidney disease to regulate fluid balance and continually eliminate metabolic waste products. For example, as reported by the Centers for Disease Control and Prevention in July 2022, kidney disease affected approximately 15% of the US population, amounting to 37 million individuals. Additionally, the Australian Institute of Health and Welfare noted an increase in the prevalence of kidney replacement therapy from 94 to 95.4 per 100,000 population between 2019 and 2020. This trend underscores the growing demand for continuous renal replacement therapy.

Leading companies in the continuous renal replacement therapy market are focusing on developing advanced products such as continuous renal replacement therapy (CRRT) platforms to cater to customers with enhanced features. CRRT platforms encompass systems and technologies utilized in delivering CRRT, a dialysis method primarily prescribed for critically ill patients unable to undergo regular hemodialysis. For instance, Baxter International Inc. introduced the Prismax 2 platform in May 2021, designed to streamline the administration of continuous renal replacement therapy and other organ support therapies. This platform, featuring the Prismalung+ blood-gas exchanger from Baxter’s TrueVue digital health portfolio, offers hospitals the flexibility needed to address ICU challenges and includes extracorporeal carbon dioxide removal (ECCO2R) therapy for acute respiratory dysfunction management.

In December 2021, Baxter International Inc. completed the acquisition of Hillrom for $12.5 billion, strategically expanding its product range and expertise in hospital equipment and digital health. This acquisition strengthens Baxter’s position as a global leader in medical technology, aligning with its mission to revolutionize healthcare and improve patient care worldwide. Hillrom, a US-based provider of continuous renal replacement therapy, joins forces with Baxter to advance medical technology innovation and enhance patient outcomes.

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

North America was the largest region in the continuous renal replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous renal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Continuous renal replacement therapy (CRRT) is a form of dialysis that provides gradual, ongoing blood filtration to help regulate levels of fluids, electrolytes, and waste products in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It plays a crucial role in managing fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal through intermittent hemodialysis due to cardiovascular instability.

The primary products in the continuous renal replacement therapy market are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device utilized in treating critically ill patients with AKI or other renal conditions. It offers various renal and non-renal therapies using different modalities such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These therapies are administered to adults, pediatrics, and neonates in various settings including hospitals, ambulatory care centers, and homecare setups.

The continuous renal replacement therapy market research report is one of a series of new reports that provides continuous renal replacement therapy market statistics, including continuous renal replacement therapy industry global market size, regional shares, competitors with a continuous renal replacement therapy market share, detailed continuous renal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy industry. This continuous renal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Continuous Renal Replacement Therapy Market Characteristics3. Continuous Renal Replacement Therapy Market Trends and Strategies
4. Continuous Renal Replacement Therapy Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Continuous Renal Replacement Therapy Market Size and Growth
5.1. Global Continuous Renal Replacement Therapy Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Continuous Renal Replacement Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Continuous Renal Replacement Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Continuous Renal Replacement Therapy Market Segmentation
6.1. Global Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • System
  • Consumables
6.2. Global Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Renal
  • Non-Renal
6.3. Global Continuous Renal Replacement Therapy Market, Segmentation by Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
6.4. Global Continuous Renal Replacement Therapy Market, Segmentation by Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adults
  • Pediatrics Or Neonates
6.5. Global Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Care
  • Homecare
7. Continuous Renal Replacement Therapy Market Regional and Country Analysis
7.1. Global Continuous Renal Replacement Therapy Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Continuous Renal Replacement Therapy Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Continuous Renal Replacement Therapy Market
8.1. Asia-Pacific Continuous Renal Replacement Therapy Market Overview
(Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies)
8.2. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Continuous Renal Replacement Therapy Market
9.1. China Continuous Renal Replacement Therapy Market Overview
9.2. China Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Continuous Renal Replacement Therapy Market
10.1. India Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Continuous Renal Replacement Therapy Market
11.1. Japan Continuous Renal Replacement Therapy Market Overview
11.2. Japan Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Continuous Renal Replacement Therapy Market
12.1. Australia Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Continuous Renal Replacement Therapy Market
13.1. Indonesia Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Continuous Renal Replacement Therapy Market
14.1. South Korea Continuous Renal Replacement Therapy Market Overview
14.2. South Korea Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Continuous Renal Replacement Therapy Market
15.1. Western Europe Continuous Renal Replacement Therapy Market Overview
15.2. Western Europe Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Continuous Renal Replacement Therapy Market
16.1. UK Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Continuous Renal Replacement Therapy Market
17.1. Germany Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Continuous Renal Replacement Therapy Market
18.1. France Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Continuous Renal Replacement Therapy Market
19.1. Italy Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Continuous Renal Replacement Therapy Market
20.1. Spain Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Continuous Renal Replacement Therapy Market
21.1. Eastern Europe Continuous Renal Replacement Therapy Market Overview
21.2. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Continuous Renal Replacement Therapy Market
22.1. Russia Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Continuous Renal Replacement Therapy Market
23.1. North America Continuous Renal Replacement Therapy Market Overview
23.2. North America Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Continuous Renal Replacement Therapy Market
24.1. USA Continuous Renal Replacement Therapy Market Overview
24.2. USA Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Continuous Renal Replacement Therapy Market
25.1. Canada Continuous Renal Replacement Therapy Market Overview
25.2. Canada Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Continuous Renal Replacement Therapy Market
26.1. South America Continuous Renal Replacement Therapy Market Overview
26.2. South America Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Continuous Renal Replacement Therapy Market
27.1. Brazil Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Continuous Renal Replacement Therapy Market
28.1. Middle East Continuous Renal Replacement Therapy Market Overview
28.2. Middle East Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Continuous Renal Replacement Therapy Market
29.1. Africa Continuous Renal Replacement Therapy Market Overview
29.2. Africa Continuous Renal Replacement Therapy Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Continuous Renal Replacement Therapy Market, Segmentation by Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Continuous Renal Replacement Therapy Market, Segmentation by End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Continuous Renal Replacement Therapy Market Competitive Landscape and Company Profiles
30.1. Continuous Renal Replacement Therapy Market Competitive Landscape
30.2. Continuous Renal Replacement Therapy Market Company Profiles
30.2.1. Medtronic Plc
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Fresenius Medical Care AG & Co. KGaA
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Asahi Kasei Corporation
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Toray Industries Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Baxter International Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Continuous Renal Replacement Therapy Market Other Major and Innovative Companies
31.1. B. Braun Melsungen AG
31.2. Terumo Corporation
31.3. Nipro Corporation
31.4. NxStage Medical Inc.
31.5. Hillrom Holdings Inc.
31.6. Gambro AB
31.7. JMS Co. Ltd.
31.8. Quanta Dialysis Technologies Ltd.
31.9. Bellco S.r.l.
31.10. Ningbo Tianyi Medical Devices Co. Ltd.
31.11. Cytosorbents Corporation
31.12. Kawasumi Laboratories Inc.
31.13. Medica S.p.a.
31.14. Informed SA
31.15. Medites Pharma Spol. S.R.O
32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking33. Global Continuous Renal Replacement Therapy Market Competitive Dashboard34. Key Mergers and Acquisitions in the Continuous Renal Replacement Therapy Market
35. Continuous Renal Replacement Therapy Market Future Outlook and Potential Analysis
35.1 Continuous Renal Replacement Therapy Market in 2028 - Countries Offering Most New Opportunities
35.2 Continuous Renal Replacement Therapy Market in 2028 - Segments Offering Most New Opportunities
35.3 Continuous Renal Replacement Therapy Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Continuous Renal Replacement Therapy Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous renal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for continuous renal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous renal replacement therapy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: System; Consumables
2) By Therapy: Renal; Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF); Continuous Venovenous Hemofiltration (CVVH); Continuous Venovenous Hemodialysis (CVVHD); Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults; Pediatrics Or Neonates
5) By End-Users: Hospitals; Ambulatory Care; Homecare

Key Companies Mentioned: Medtronic Plc; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Toray Industries Inc.; Baxter International Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Corporation
  • Toray Industries Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • NxStage Medical Inc.
  • Hillrom Holdings Inc.
  • Gambro AB
  • JMS Co. Ltd.
  • Quanta Dialysis Technologies Ltd.
  • Bellco S.r.l.
  • Ningbo Tianyi Medical Devices Co. Ltd.
  • Cytosorbents Corporation
  • Kawasumi Laboratories Inc.
  • Medica S.p.A.
  • Infomed SA
  • Medites Pharma Spol. S.R.O
  • Nikkiso Co. Ltd.
  • Anjue Medical Equipment Co. Ltd.
  • Medcomp Systems Ltd.

Methodology

Loading
LOADING...

Table Information